Publications by authors named "Steven Rhodes"

Claim this Profile
A
A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.
Su Jung Park, Jodi L Lukkes, Ka-Kui Chan, Hayley P Drozd, Callie B Burgin, Steven D Rhodes

J Clin Invest· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibroma.
Mohannad Abu-Sultanah, Zhuan Zhou, Chunhui Jiang, Dana K Mitchell, Waylan K Bessler, Steven D Rhodes

Sci Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An induced pluripotent stem cell model of Schwann cell differentiation reveals NF2- related gene regulatory networks.
Olivia Lazaro, Sihong Li, William Carter, Jake Smiley, Oluwamayowa Awosika, Steven D Rhodes

Res Sq· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.
Dana K Mitchell, Kylee Brewster, Stavriani C Makri, Jaffar Khan, Eric A Albright, Steven Rhodes

Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway-Deficient Acute Myeloid Leukemia.
Aditya S Sheth, Ka-Kui Chan, Sheng Liu, Jun Wan, Steve P Angus, Steven D Rhodes

Cancer Res Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.
Andrea M Gross, Geraldine O'Sullivan Coyne, Eva Dombi, Cecilia Tibery, William G Herrick, Steven D Rhodes

Nat Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group.
Elliot Stieglitz, Alex G Lee, Steven P Angus, Christopher Davis, Donald A Barkauskas, Steven D Rhodes

Cancer Discov· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel induced pluripotent stem cell model of Schwann cell differentiation reveals - related gene regulatory networks of the extracellular matrix.
Olivia Lazaro, Sihong Li, William Carter, Oluwamayowa Awosika, Sylvia Robertson, Steven D Rhodes

bioRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Antireflux "RELIEF" Stent to Prevent Vesicoureteral Reflux.
Michael Callegari, Anish Patel, Andrew Drozd, Steven Rhodes, Hannah Ahrendt

Urology· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma.
Alyssa C Flint, Dana K Mitchell, Steven P Angus, Abbi E Smith, Waylan Bessler, Steven D Rhodes

Clin Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of -null, melanoma to BRAF/MEK inhibition.
Evan DuBose, Samantha M Bevill, Dana K Mitchell, Noah Sciaky, Brian T Golitz, Steven D Rhodes

Front Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.
Dana K Mitchell, Breanne Burgess, Emily E White, Abbi E Smith, Elizabeth A Sierra Potchanant, Steven D Rhodes

Clin Cancer Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials.
R Taylor Sundby, Steven D Rhodes, Edina Komlodi-Pasztor, Herb Sarnoff, Vito Grasso

Clin Trials· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The +/- Immune Microenvironment: Dueling Roles in Neurofibroma Development and Malignant Transformation.
Emily E White, Steven D Rhodes

Cancers (Basel)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma.
Alyssa C Flint, Dana K Mitchell, Steven P Angus, Abbi E Smith, Waylan Bessler, Steven D Rhodes

Clin Cancer Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.
Steven D Rhodes, Frank McCormick, Ross L Cagan, Annette Bakker, Verena Staedtke

J Invest Dermatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target Product Profile for Cutaneous Neurofibromas: Clinical Trials to Prevent, Arrest, or Regress Cutaneous Neurofibromas.
Ina Ly, Carlos G Romo, Sally Gottesman, Kristen M Kelly, Deanna Kornacki, Steven D Rhodes

J Invest Dermatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.
Verena Staedtke, Piotr Topilko, Lu Q Le, Kevin Grimes, David A Largaespada, Steven D Rhodes

J Invest Dermatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Call for Discovery and Therapeutic Development for Cutaneous Neurofibromas.
Jaishri O Blakeley, Lu Q Le, Sang Y Lee, Ina Ly, Steven D Rhodes

J Invest Dermatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas.
Evan C Cumpston, Steven D Rhodes, Charles W Yates

Curr Oncol Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.
Silpa Gampala, Fenil Shah, Chi Zhang, Steven D Rhodes, Olivia Babb

Br J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SIK2 kinase synthetic lethality is driven by spindle assembly defects in FANCA-deficient cells.
Ka-Kui Chan, Zahi Abdul-Sater, Aditya Sheth, Dana K Mitchell, Richa Sharma, Steven D Rhodes

Mol Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.
Silpa Gampala, Fenil Shah, Chi Zhang, Steven D Rhodes, Olivia Babb

Br J Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.
Michael J Fisher, Chie-Schin Shih, Steven D Rhodes, Amy E Armstrong, Pamela L Wolters

Nat Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 17.
Julie A Mund, SuJung Park, Abbi E Smith, Yongzheng He, Li Jiang, Steven D Rhodes

J Biol Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis